Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly Extends Cholesterol Therapy Study on Panel’s Recommendation
Lilly Extends Cholesterol Therapy Study on Panel’s Recommendation
Lilly Extends Cholesterol Therapy Study on Panel’s Recommendation
Submitted by
admin
on February 19, 2015 - 10:42am
Source:
WSJ Online
News Tags:
Eli Lilly
advisory panels
FDA
evacetrapib
Headline:
Lilly Extends Cholesterol Therapy Study on Panel’s Recommendation
Do Not Allow Advertisers to Use My Personal information
